טוען...
Debating medicalization of Female Genital Mutilation/Cutting (FGM/C): learning from (policy) experiences across countries
BACKGROUND: Although Female Genital Mutilation/Cutting (FGM/C) is internationally considered a harmful practice, it is increasingly being medicalized allegedly to reduce its negative health effects, and is thus suggested as a harm reduction strategy in response to these perceived health risks. In ma...
שמור ב:
| הוצא לאור ב: | Reprod Health |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6823951/ https://ncbi.nlm.nih.gov/pubmed/31675972 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12978-019-0817-3 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|